A personal weekly update from a creator documenting a year on tirzepatide, now marking a 100 pound drop from their highest weight.
Recap by typeshit. Full story at Riding the -tide.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
GoodRx keeps a running page on peptide regulation news, with a focus on what the FDA is doing about compounding pharmacies.
The large study looked at people with both schizophrenia and diabetes taking drugs like Ozempic. Quartz notes the findings come with caveats.
Loading…